Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
lung cancer treatment
Aug 5, 2024, 04:49 |
Drugs
Maria Babak: Key highlight from The Babak Lab on FDA Approval for Adagrasib
Maria Babak shared a post by The Babak Lab on LinkedIn: "This FDA approval represents…
Aug 4, 2024, 23:39 |
Insight
HERALD EPOC1806 study explores trastuzumab deruxtecan in solid tumors with HER2 amplification by ctDNA
Stephen Liu shared a post on X: "HERALD EPOC1806 study published in JCO explored trastuzumab…
Aug 4, 2024, 07:57 |
Blog
Rob Winn: An honor to host a distinguished delegation from the Cuban Embassy and Center of Molecular Immunology in Havana
Rob Winn, Director at VCU Massey Cancer Center, shared a post on LinkedIn: "It was…
Aug 4, 2024, 06:02 |
Blog
Rahul Gosain: With Patrick Forde we discuss the SoC for early and locally advanced NSCLC
Rahul Gosain shared on LinkedIn: "Lung Series: with Patrick Forde we discuss the SoC for…
Aug 3, 2024, 10:13 |
Drugs
Harpreet Singh: ODAC vote marks a pivotal moment in oncology drug development
Harpreet Singh, Chief Medical Officer at Precision For Medicine, shared on LinkedIn: "The recent FDA…
Aug 3, 2024, 07:34 |
Blog
Paolo Tarantino: When diagnosing ILD, the radiologist is your best friend
Paolo Tarantino shared on LinkedIn: "When diagnosing Interstitial Lung Disease (ILD), the radiologist is your…
Aug 2, 2024, 12:21 |
Blog
Session Highlights on Irradiation Volume and SBRT Optimisation at ESTRO24
ESTRO (European Society for Radiotherapy and Oncology) shared a post on LinkedIn: ''Comprehensive report on…
Aug 2, 2024, 07:13 |
Blog
Stephen Liu: Experience with 1000 robotic assisted lobectomies at a single center
Stephen Liu shared on X: "Experience with 1000 robotic assisted lobectomies at a single center.…
Aug 1, 2024, 13:21 |
Opinion
Stephen Liu: The seminal PROFILE 1001 trial of crizotinib in ALK and ROS1 NSCLC
Stephen Liu shared on X: "Watch for a special episode of the IASLC podcast, Lung Cancer…
Jul 31, 2024, 14:18 |
Blog
Formycon announced start of clinical phase III trial for Keytruda biosimilar candidate FYB206
Formycon AG announced that the first patient has been enrolled in the Phase III clinical…
56
57
58
59
60
All:
856
Posts:
571 - 580
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube